Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)... Wikipedia

Manufacturer's Website: Symlin

Average retail cost: $1,777/carton